Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase 1/2 1

Status

Completed 5Terminated 1Recruiting 1

Sponsor Class

OTHER 7INDUSTRY 1

Study Type

Interventional 7

Sponsor

Cancer Type

Genitourinary 7

Conditions

Prostatic Neoplasms 7Stage II Prostate Adenocarcinoma 1Prostate Adenocarcinoma 1Breast Neoplasms 1

Interventions

Docetaxel 171Radiotherapy 144Magnetic Resonance Spectroscopy 142Leuprolide 112Prednisone 108enzalutamide 102Radiosurgery 101Abiraterone Acetate 94Androgen Antagonists 91Goserelin 83bicalutamide 81gallium 68 PSMA-11 70Surveys and Questionnaires 63apalutamide 57Specimen Handling 56acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 55Radiation 47Gonadotropin-Releasing Hormone 45Standard of Care 44Biopsy 44Brachytherapy 42Radiotherapy, Intensity-Modulated 40Blood Specimen Collection 40darolutamide 39abiraterone 39cabazitaxel 35Exercise 35Carboplatin 33Pluvicto 32Triptorelin Pamoate 31

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
OTHER × Prostatic Neoplasms × BAY 86-7548 × Clear all
NCT06484361 2024-07-03

PET/MRI to Stage Prostate Cancer Patients

IRCCS San Raffaele

Phase 2 Recruiting
50 enrolled
Genitourinary

Prostatic Neoplasms

NCT04264208 2024-02-01

HDR Brachytherapy 68-Ga-RM2 PET, 68-Ga-PSMA-11 PET &Multi Parametric MRI in Prostate Cancer

Stanford University

Phase 2 Terminated
4 enrolled 7 charts
Genitourinary

Prostatic Neoplasms

NCT03949517 2024-01-30

68-Ga PSMA 11 PET/MRI and 68-Ga RM2 PET/MRI for Evaluation of Prostate Cancer Response to HIFU Therapy

Stanford University

Phase 1/2 Completed
14 enrolled 7 charts
Genitourinary

Prostatic Neoplasms

NCT03809078 2024-01-11

68Ga PSMA 11 PET/MRI and 68Ga RM2 PET/MRI for Biopsy Guidance in Patients With Suspected Prostate Cancer

Stanford University

Phase 2 Completed
14 enrolled 7 charts
Genitourinary

Prostatic Neoplasms

NCT05806853 2023-04-10

PET/MR for Prostate Cancer Restaging: a Phase II Prospective Monocentric Study

IRCCS San Raffaele

Phase 2 Completed
60 enrolled
Genitourinary

Prostatic Neoplasms

NCT02559115 2021-05-18

68Ga-RM2 for PET/CT of Gastrin Releasing Peptide Receptor (GRPr) Expression in Prostate Cancer

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
19 enrolled 5 charts
Genitourinary

Prostatic Neoplasms

NCT02440308 2017-04-11

68Ga-DOTA-Bombesin PET/MRI in Imaging Patients With Prostate Cancer

Stanford University

Phase 2 Completed
10 enrolled 4 charts
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡